98 related articles for article (PubMed ID: 22660809)
1. Vascular leak is a central feature in the pathogenesis of systemic sclerosis.
Frech TM; Revelo MP; Drakos SG; Murtaugh MA; Markewitz BA; Sawitzke AD; Li DY
J Rheumatol; 2012 Jul; 39(7):1385-91. PubMed ID: 22660809
[TBL] [Abstract][Full Text] [Related]
2. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
Fleming JN; Shulman HM; Nash RA; Johnson PY; Wight TN; Gown A; Schwartz SM
PLoS One; 2009 Jul; 4(7):e6203. PubMed ID: 19587802
[TBL] [Abstract][Full Text] [Related]
4. A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.
Giusti B; Fibbi G; Margheri F; Serratì S; Rossi L; Poggi F; Lapini I; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Gensini GF; Del Rosso M; Abbate R
Arthritis Res Ther; 2006; 8(4):R115. PubMed ID: 16859528
[TBL] [Abstract][Full Text] [Related]
5. Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.
Moroncini G; Svegliati S; Grieco A; Cuccioloni M; Mozzicafreddo M; Paolini C; Agarbati S; Spadoni T; Amoresano A; Pinto G; Chen Q; Benfaremo D; Tonnini C; Senzacqua M; Alizzi S; Nieto K; Finke D; Viola N; Amico D; Galgani M; Gasparini S; Zuccatosta L; Menzo S; Müller M; Kleinschmidt J; Funaro A; Giordano A; La Cava A; Dorfmüller P; Amoroso A; Pucci P; Pezone A; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2024 Apr; 76(4):620-630. PubMed ID: 37975161
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.
Rius Rigau A; Li YN; Matei AE; Györfi AH; Bruch PM; Koziel S; Devakumar V; Gabrielli A; Kreuter A; Wang J; Dietrich S; Schett G; Distler JHW; Liang M
Circ Res; 2024 Mar; 134(7):875-891. PubMed ID: 38440901
[TBL] [Abstract][Full Text] [Related]
7. [Update on targeted biopharmaceuticals in systemic sclerosis!].
Chaigne B; Mouthon L
Rev Med Interne; 2024 Feb; 45(2):109-113. PubMed ID: 37980267
[TBL] [Abstract][Full Text] [Related]
8. Role of NLRP3 inflammasome in systemic sclerosis.
Lin C; Jiang Z; Cao L; Zou H; Zhu X
Arthritis Res Ther; 2022 Aug; 24(1):196. PubMed ID: 35974386
[TBL] [Abstract][Full Text] [Related]
9. Dermal Microvascular Units in Domestic Pigs (
Meng X; Zhu Z; Ahmed N; Ma Q; Wang Q; Deng B; Chen Q; Lu Y; Yang P
Front Vet Sci; 2022; 9():891286. PubMed ID: 35548054
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.
Burg N; Salmon JE; Hla T
Nat Rev Rheumatol; 2022 Jun; 18(6):335-351. PubMed ID: 35508810
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease.
Birnhuber A; Jandl K; Biasin V; Fließer E; Valzano F; Marsh LM; Krolczik C; Olschewski A; Wilhelm J; Toller W; Heinemann A; Olschewski H; Wygrecka M; Kwapiszewska G
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35332068
[TBL] [Abstract][Full Text] [Related]
12. Multiple subregions within the caveolin-1 scaffolding domain inhibit fibrosis, microvascular leakage, and monocyte migration.
Reese CF; Chinnakkannu P; Tourkina E; Hoffman S; Kuppuswamy D
PLoS One; 2022; 17(2):e0264413. PubMed ID: 35213624
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma.
Tsou PS; Palisoc PJ; Flavahan NA; Khanna D
Arthritis Rheumatol; 2021 Mar; 73(3):520-529. PubMed ID: 33001586
[TBL] [Abstract][Full Text] [Related]
14. Gut disease in systemic sclerosis - new approaches to common problems.
Zhu J; Frech T
Curr Treatm Opt Rheumatol; 2019 Mar; 5(1):11-19. PubMed ID: 31750073
[TBL] [Abstract][Full Text] [Related]
15. Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment.
Frech TM; Machin DR; Murtaugh MA; Stoddard GJ; Bloom SI; Phibbs JV; Donato AJ
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):175-182. PubMed ID: 30277867
[TBL] [Abstract][Full Text] [Related]
16. Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
Bruni C; Frech T; Manetti M; Rossi FW; Furst DE; De Paulis A; Rivellese F; Guiducci S; Matucci-Cerinic M; Bellando-Randone S
Front Immunol; 2018; 9():2045. PubMed ID: 30245695
[TBL] [Abstract][Full Text] [Related]
17. The safety of iloprost in systemic sclerosis in a real-life experience.
Bellando-Randone S; Bruni C; Lepri G; Fiori G; Bartoli F; Conforti ML; Moggi-Pignone A; Guiducci S; Giuggioli D; Colaci M; Spinella A; Ferri C; Matucci-Cerinic M
Clin Rheumatol; 2018 May; 37(5):1249-1255. PubMed ID: 29470737
[TBL] [Abstract][Full Text] [Related]
18. Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.
Machin DR; Clifton HL; Richardson RS; Wray DW; Donato AJ; Frech TM
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):167-172. PubMed ID: 28980911
[TBL] [Abstract][Full Text] [Related]
19. Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study.
Machin DR; Gates PE; Vink H; Frech TM; Donato AJ
J Rheumatol; 2017 Nov; 44(11):1603-1611. PubMed ID: 28916547
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
